The Indian Express 28 Feb 2021:

RhD happens due to Rh incompatibility, when mother is Rh negative and baby in her womb is Rhpositive. The mother’s body responds to the Rhpositive blood by producing antibodies. Subsequently, during her second pregnancy with Rhpositive baby, her body produces antibodies immediately. These antibodies can cross the placenta from the mother to unborn child and attack the baby’s RBCs. This poses as a serious challenge for the unborn baby and needs appropriate management.

Read more:

About BSV

BSV has been a pioneer in the development of blood components and therapeutic antibody products for infectious and non-infectious diseases. For over four decades, BSVL has focused on utilizing its scientific resources to develop several biological, biotechnology and pharmaceutical products to treat various types of diseases, contributing to preserve, protect and enhance the quality of life. We aim to be a leading biopharmaceutical company driven by people & science to set benchmarks in patient outcomes in Women’s Health, Critical Care & Emergency Medicine.

For more information, please contact:

Irawati Gowariker, BSV, Irawati.gowariker@bsvgroup.com